104. Marston MT, Berben L, Dobbels F, Russell CL, de Geest S. Prevalence and Patient-Level Correlates of Intentional Non-Adherence to Immunosuppressive Medication After Heart-Transplantation-Findings From the International BRIGHT Study. Transpl Int. 2023 Jul 10;36:11308. doi: 10.3389/ti.2023.11308. PMID: 37492859; PMCID: PMC10363605. [Link] 103. Oruç A, Ersoy A, Can FE, et al. Transculturally adaptation and validation of the basel assessment of adherence to immunosuppressive medication scale (BAASIS©) interview questionnaire among Turkish kidney transplant recipients. Turk J Nephrol. 2023;32(3):235-240. 102. Magalhães, A.L.P.; Campos, T.S.; Lima, V.G.K.; Lins, S.M.S.B.; Souza, E.; Adesão à terapia imunossupressora de transplantados renais de um hospital universitário. saúdecoletiva 2019; 51; 1892-1898. 101. Wagner-Skacel J, Fink N, Kahn J, Dalkner N, Jauk E, Bengesser S, Mairinger M, Schüssler G, Pieh C, Stadlbauer V, Kirsch AH, Zitta S, Rosenkranz AR, Fickert P, Schemmer P. Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study. Front Psychol. 2023 Mar 9;14:1150548. doi: 10.3389/fpsyg.2023.1150548. PMID: 36968754; PMCID: PMC10033957. [Link] 100. Denhaerynck K, Dobbels F, Košťálová B, De Geest S; BAASIS consortium. Psychometric Properties of the BAASIS: A Meta-analysis of Individual Participant Data. Transplantation. 2023 Mar 23. doi: 10.1097/TP.0000000000004574. Epub ahead of print. PMID: 36949037. [Link] 99. Elias C, Cherukuri A. BAASIS for Monitoring Therapy Nonadherence in Clinical Transplantation: Are We There Yet? Transplantation. 2023 Mar 23. doi: 10.1097/TP.0000000000004575. Epub ahead of print. PMID: 36949031. [Link] 98. Shafiekhani M, Shahabinezhad F, Tavakoli Z, Tarakmeh T, Haem E, Sari N, Nasirabadi S, Dehghani M. Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study. Front Pharmacol. 2023 Feb 24;14:1051350. doi: 10.3389/fphar.2023.1051350. PMID: 36909168; PMCID: PMC9998979. [Link] 97. Kosoku A, Iwai T, Masuda H, Kabei K, Nishide S, Maeda K, Yoshikawa Y, Nakamura Y, De Geest S, Uchida J. Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients. Transplant Direct. 2023 Feb 24;9(3):e1457. doi: 10.1097/TXD.0000000000001457. PMID: 36860659; PMCID: PMC9970284. [Link] 96. Bartlett Ellis RJ, Andrews A, Elomba CD, Remy LM, Ruggeri SY, Russell CL, Ruppar TM. Managing Medications and Medication Adherence Among US Adults During the Early Phase of the COVID-19 Pandemic. Patient Prefer Adherence. 2023 Feb 11;17:369-383. doi: 10.2147/PPA.S393749. PMID: 36819643; PMCID: PMC9930569. [Link] 95. Verma M, Zaki R, Sadeh J, Knorr JP, Gallagher M, Parsikia A, Navarro V. Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial. J Transplant. 2023 Jan 4;2023:7915781. doi: 10.1155/2023/7915781. PMID: 36642992; PMCID: PMC9833930. [Link] 94. Vaisbourd Y, Dahhou M, Zhang X, Sapir-Pichhadze R, Cardinal H, Johnston O, Blydt-Hansen TD, Tibbles LA, Hamiwka L, Urschel S, Birk P, Bissonnette J, Matsuda-Abedini M, BScPhm JH, Schiff J, Phan V, De Geest S, Allen U, Avitzur Y, Mital S, Foster BJ. Differences in medication adherence by sex and organ type among adolescent and young adult solid organ transplant recipients. Pediatr Transplant. 2022 Dec 7:e14446. doi: 10.1111/petr.14446. Epub ahead of print. PMID: 36478059. [Link] 93. Kostalova B, Mala-Ladova K, Sulkova SD, Denhaerynck K, De Geest S, Maly J. Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence. Front Pharmacol. 2022 Oct 13;13:973564. doi: 10.3389/fphar.2022.973564. PMID: 36313323; PMCID: PMC9609782. [Link] 92. Chen T, Wang Y, Tian D, Zhang J, Xu Q, Lv Q, Li X, Wang J. Follow-Up Factors Contribute to Immunosuppressant Adherence in Kidney Transplant Recipients. Patient Prefer Adherence. 2022 Oct 19;16:2811-2819. doi: 10.2147/PPA.S383243. PMID: 36284546; PMCID: PMC9588292. [Link] 91. De Geest S, Valenta S, Ribaut J, Gerull S, Mielke J, Simon M, Bartakova J, Kaier K, Eckstein J, Leppla L, Teynor A; SMILe team. The SMILe integrated care model in allogeneic SteM cell TransplantatIon faciLitated by eHealth: a protocol for a hybrid effectiveness-implementation randomised controlled trial. BMC Health Serv Res. 2022 Aug 20;22(1):1067. doi: 10.1186/s12913-022-08293-8. PMID: 35987671; PMCID: PMC9392360. [Link] 90. Vengadessane S, Viglietti D, Sauvageon H, Glotz D, Lefaucheur C, Madelaine I, Deville L. Adhésion médicamenteuse en greffe rénale: évaluation, facteurs prédictifs et impact sur l’allo-réactivité humorale [Medication adherence in renal transplantation: evaluation, predictive factors and impact on humoral alloreactivity]. Ann Pharm Fr. 2022 Jul 2:S0003-4509(22)00085-2. French. doi: 10.1016/j.pharma.2022.06.011. Epub ahead of print. PMID: 35792151. [Link] 89. Yang G, Liu J, Zhao H, Yan J, Wu X. Characteristic of medication compliance behavior in renal transplantation patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):762-770. English, Chinese. doi: 10.11817/j.issn.1672-7347.2022.210666. PMID: 35837776. [Link] 88. Tong A, Oberbauer R, Bellini MI, Budde K, Caskey FJ, Dobbels F, Pengel L, Rostaing L, Schneeberger S, Naesens M. Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions. Transpl Int. 2022 May 20;35:10134. doi: 10.3389/ti.2022.10134. PMID: 35669971; PMCID: PMC9163311. [Link] 87. Zachciał J, Uchmanowicz I, Czapla M, Krajewska M, Banasik M. The Association between Psychosocial and Age-Related Factors with Adherence to Immunosuppressive Therapies after Renal Transplantation. J Clin Med. 2022 Apr 24;11(9):2386. doi: 10.3390/jcm11092386. PMID: 35566514; PMCID: PMC9105664. [Link] 86. Ali A, Al-Taee HA, Jasim MS. Adherence to Immunosuppressive Medication in Iraqi Kidney Transplant Recipients During the First Year of Transplant. A Single-Center Experience. Exp Clin Transplant. 2022 Mar;20(Suppl 1):107-112. doi: 10.6002/ect.MESOT2021.P44. PMID: 35384818. [Link] 85. Wang Y, Veltkamp DMJ, van der Boog PJM, Hemmelder MH, Dekker FW, de Vries APJ, Meuleman Y. Illness Perceptions and Medication Nonadherence to Immunosuppressants After Successful Kidney Transplantation: A Cross-Sectional Study. Transpl Int. 2022 Feb 7;35:10073. doi: 10.3389/ti.2022.10073. PMID: 35185376; PMCID: PMC8842226. [Link] 84. Wessels-Bakker MJ, van de Graaf EA, Kwakkel-van Erp JM, Heijerman HG, Cahn W, Schappin R. The relation between psychological distress and medication adherence in lung transplant candidates and recipients: A cross-sectional study. J Clin Nurs. 2022 Mar;31(5-6):716-725. doi: 10.1111/jocn.15931. Epub 2021 Jul 2. PMID: 34216066; PMCID: PMC9292052. [Link] 83. Maurer MM, Ibach M, Plewe J, Winter A, Ritschl P, Globke B, Öllinger R, Lurje G, Schöning W, Pratschke J, Eurich D. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines. 2022 Jan 26;10(2):272. doi: 10.3390/biomedicines10020272. PMID: 35203481; PMCID: PMC8869578. [Link] 82. Kostalova B, Mala-Ladova K, Kubena AA, Horne R, Dusilova Sulkova S, Maly J. Changes in Beliefs About Post-Transplant Immunosuppressants Over Time and Its Relation to Medication Adherence and Kidney Graft Dysfunction: A Follow-Up Study. Patient Prefer Adherence. 2021 Dec 31;15:2877-2887. doi: 10.2147/PPA.S344878. PMID: 35002225; PMCID: PMC8725840. [Link] 81. Pourrat X, Berthy E, Dupuis A, Barbier L, Buchler M, Guillon LG, Monmousseau F, Ruspini E, Salamé E, Houdard SB, Giraudeau B. Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH). Trials. 2021 Nov 8;22(1):782. doi: 10.1186/s13063-021-05749-w. Erratum in: Trials. 2022 May 24;23(1):438. PMID: 34749777; PMCID: PMC8573912. [Link] 80. van Zanten R, de Weerd A, Betjes M, Boer-Verschragen M, Massey EK. Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transpl Int. 2021 Sep;34(9):1703-1711. doi: 10.1111/tri.13993. PMID: 34448273. [Link] 79. Cheung CY, Chan KM, Tang G, Cheung A, Chak WL. Immunosuppressive medication adherence in kidney transplant recipients during COVID-19 pandemic: a cross sectional study in Hong Kong. Transplant Proc. 2021 Aug 16. doi: 10.1016/j.transproceed.2021.08.018. Epub ahead of print. PMCID: PMC8364813. [Link] 78. Dabirzadeh A, Dahhou M, Zhang X, Sapir-Pichhadze R, Cardinal H, White M, Johnston O, Blydt-Hansen TD, Tibbles LA, Hamiwka L, Urschel S, Birk P, Bissonnette J, Matsuda-Abedini M, Harrison J, Schiff J, Phan V, De Geest S, Allen U, Mital S, Foster BJ. Care processes and structures associated with higher medication adherence in adolescent and young adult transplant recipients. Pediatr Transplant. 2021 Aug 2:e14106. doi: 10.1111/petr.14106. Epub ahead of print. PMID: 34339090. [Link] 77. Herblum J, Dacouris N, Huang M, Zaltzman J, Prasad GVR, Nash M, Chen L. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence. Can J Kidney Health Dis. 2021 Jun 15;8:20543581211021742. doi: 10.1177/20543581211021742. PMID: 34188946; PMCID: PMC8209833. [Link] 76. Marsicano-Souza EO, Colugnati F, Geest S, Sanders-Pinheiro H. Nonadherence to immunosuppressives and treatment in kidney transplant: ADHERE BRAZIL Study. Rev Saude Publica. 2021 May 31;55:33. doi: 10.11606/s1518-8787.2021055002894. PMID: 34076208; PMCID: PMC8139843. [Link] 75. Zhang P, Zhu X, Yan J, Liu J. Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients: 6-12. Front Pharmacol. 2021 May 26;12:655836. doi: 10.3389/fphar.2021.655836. PMID: 34122077; PMCID: PMC8187913. [Link] 74. Krause AV, Bertram A, Nöhre M, Bauer-Hohmann M, Schiffer M, de Zwaan M. Use of an electronic medication monitoring device to estimate medication adherence in kidney transplant patients. Transl Behav Med. 2021 Apr 7;11(3):842-851. doi: 10.1093/tbm/ibaa122. PMID: 33710349. [Link] 73. Godinas L, Dobbels F, Hulst L, Verbeeck I, De Coninck I, Berrevoets P, Schaevers V, Yserbyt J, Dupont LJ, Verleden SE, Vanaudenaerde BM, Ceulemans LJ, Van Raemdonck DE, Neyrinck A, Verleden GM, Vos R. Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence. J Heart Lung Transplant. 2021 Jun;40(6):467-477. doi: 10.1016/j.healun.2021.02.017. Epub 2021 Feb 27. PMID: 33840608. [Link] 72. Liu J, Zhu X, Yan J, Gong L, Wu X, Liu M, Mao P. Association Between Regulatory Emotional Self-Efficacy and Immunosuppressive Medication Adherence in Renal Transplant Recipients:Does Medication Belief Act as a Mediator? Front Pharmacol. 2021 Mar 8;12:559368. doi: 10.3389/fphar.2021.559368. PMID: 33762931; PMCID: PMC7982474. [Link] 71. Bonani M, Balaphas A, Bedino G, Bühler L, Dutkowski P, Fausch K, Gluderer S, Graf N, Hirt-Minkowski P, Müllhaupt B, Schönholzer C, Schulz MM, Venzin R, Wüthrich RP. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland. Swiss Med Wkly. 2021 Feb 18;151:w20453. doi: 10.4414/smw.2021.20453. PMID: 33638353. [Link] 70. Forsberg A, Kisch AM, Paulsson A, Ragntoft C, Dalvindt M, Lennerling A. Fear of graft rejection after heart transplantation – a nationwide cross-sectional cohort study. Eur J Cardiovasc Nurs. 2021 Jan 1;20(1):71-79. doi: 10.1177/1474515120937838. PMID: 33570598. [Link] 69. Poltronieri NVG, Moreira RSL, Schirmer J, Roza BA. Medication non-adherence in heart transplant patients. Rev Esc Enferm USP. 2020 Dec 7;54:e03644. Portuguese, English. doi: 10.1590/S1980-220X2019009203644. PMID: 33295526. [Link] 68. Fellström B, Holmdahl J, Sundvall N, Cockburn E, Kilany S, Wennberg L. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden. Transplant Proc. 2020 Dec;52(10):3238-3245. doi: 10.1016/j.transproceed.2020.06.002. Erratum for: Transplant Proc. 2018 Dec;50(10):3275-3282. PMID: 33218668. [Link] 67. Maximo Silva AC, Sanders-Pinheiro H, Leite RF, Joseph MPC, Pestana JOM, Schirmer J, Bartira de Aguiar R. Nonadherence to Immunosuppressive Medications Following Pediatric Kidney Transplantation Within Full Cost Coverage Health System: Prevalence and Correlates. Exp Clin Transplant. 2020 Oct;18(5):577-584. doi: 10.6002/ect.2020.0101. PMID: 33143602. [Link] 66. Guldager TB, Hyldgaard C, Hilberg O, Bendstrup E. An E-Learning Program Improves Patients’ Knowledge After Lung Transplantation. Telemed J E Health. 2020 Oct 9. doi: 10.1089/tmj.2020.0101. Epub ahead of print. PMID: 33035148. [Link] 65. Aladwan S, Harrison JJ, Blackburn DF, Taylor J, Blydt-Hansen TD, Mansell H. A Canadian Survey on Adverse Symptoms Experienced by Solid Organ Transplant Recipients. Prog Transplant. 2020 Sep;30(3):254-264. doi: 10.1177/1526924820933821. Epub 2020 Jun 29. PMID: 32597328. [Link] 64. Lieb M, Hepp T, Schiffer M,Opgenoorth M, Erim Y. Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation – a prospective study. BMC Nephrol. 2020 Mar 31;21(1):114. doi: 10.1186/s12882-020-01781-1. [Link] 63. Sanders-Pinheiro H, Colugnati FAB, Denhaerynck K, Marsicano EO, Medina JOP, De Geest S; ADHERE BRAZIL Study Team. Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients the Multicenter ADHERE BRAZIL Study. Transplantation. 2020 Mar 2. doi: 10.1097/TP.0000000000003214. [Link] 62. Pacleb A, Lowres N, Randall S, Neubeck L, Gallagher R. Adherence to Cardiac Medications in Patients With Atrial Fibrillation: A Pilot Study. Heart Lung Circ. 2019 Dec 17. pii: S1443-9506(19)31539-2. doi: 10.1016/j.hlc.2019.11.012. [Link] 61. Zhang M, Zhou H, Nelson RS, Han Y, Wang Y, Xiang H, Cai J, Zhang J, Yuan Y. Prevalence and Risk Factors of Immunosuppressant Nonadherence in Heart Transplant Recipients: A Single-Center Cross-Sectional Study. Patient Prefer Adherence. 2019 Dec 20;13:2185-2193. doi: 10.2147/PPA.S223837. [Link] 60. Han A, Min S, Ahn SI, Min AK, Hong HJ, Han N, Kim YS, Ahn C, Ha J. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial. PLoS One. 2019; 14(11): e0224595. doi: 10.1371/journal.pone.0224595. [Link] 59. Ganjal Ri, Sabbagh MG, Nazemiyan F, Mamdouhi M, Aval SB, Taherzadeh Z, Nabavi FH, Golmakani R, Tohidinezhad F, Eslami S. Factors Associated With Adherence To Immunosuppressive Therapy And Barriers In Asian Kidney Transplant Recipients. Immunotargets Ther. 2019; 8: 53–62. doi: 10.2147/ITT.S212760. [Link] 58. Moradi O, Karimzadeh I, Davani-Davari D, Shafiekhani M, Sagheb MM. Pattern and associated factors of adherence to immunosuppressive medications in kidney transplant recipients at a referral center in Iran. Patient Prefer Adherence. 2019 May 8;13:729-738. doi: 10.2147/PPA.S198967. [Link] 57. Kobayashi S, Tsutsui J, Okabe S, Hideki I, Akaho R, Nishimura K. Medication nonadherence after kidney transplantation: an internet-based survey in Japan. Psychol Health Med. 2019 May 30:1-11. doi: 10.1080/13548506.2019. 56. Low JK, Manias E, Crawford K, Walker R, Mulley WR, Toussaint ND, Dooley M, Kennedy E, Smith CL, Nalder M, Yip D, Williams A. Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial. Sci Rep. 2019 May 22;9(1):7734. doi: 10.1038/s41598-019-44002-y. [Link] 55. Xia M, Yan J, Liu S, Liu J. Beliefs of Immunosuppressive Medication Among Chinese Renal Transplant Recipients, as Assessed in a Cross-Sectional Study With the Basel Assessment of Adherence to Immunosuppressive Medications Scale. Transplant Proc. 2019 Apr;51(3):742-748. doi: 10.1016/j.transproceed.2018.10.029. [Link] 54. Mansell H, Rosaasen N, West-Thielke P, Wichart J, Daley C, Mainra R, Shoker A, Liu J, Blackburn D. Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol. BMJ Open. 2019 Mar 13;9(3):e025495. doi: 10.1136/bmjopen-2018-025495. [Link] 53. Helmy R, Scalso de Almeida S, Denhaerynck K, Berben L, Dobbels F, Russell CL, de Aguiar Roza B, De Geest S; BRIGHT study team. Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study. Clin Ther. 2019 Jan;41(1):130-136. doi: 10.1016/j.clinthera.2018.11.007. [Link] 52. Michaud V, Achille M, Chainey F, Phan V, Girardin C, Clermont MJ. Mixed‐methods evaluation of a transition and young adult clinic for kidney transplant recipients. Pediatr Transplant. 2019 Jun;23(4): e13450. doi: 10.1111/petr.13450. [Link] 51. Van Gaal L., Hermans M.P., Daci E., Denhaerynck K., De Meester L., MacDonald K., Abraham I., Vancayzeele S., Maris M. Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study. Diabetes Ther. 2019 Jun;10(3):965-979. doi: 10.1007/s13300-019-0601-y. [Link] 50. Ganjali R, Taherzadeh Z, Ghorban Sabbagh M, Nazemiyan F, Mamdouhi F, Tabesh H, Badiee Aval S, Golmakani R, Mostafavi S M, Eslami S. Effect of an interactive voice response system on self- management in kidney transplant recipients: Protocol for a randomized controlled trial. Medicine (Baltimore) 2019;98(6): e14291. [Link] 49. Gustavsen MT, Midtvedt K, Lonning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Asberg A. Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation. Transpl Int. 2019. 1. [Link] 48. Cossart AR, Staatz CE, Campbell SB, Isbel NM, Cottrell WN. Investigating barriers to immunosuppressant medication adherence in renal transplant patients. Nephrology (Carlton, Vic). 2019;24(1):102-10. [Link] 47. Scheel JF, Schieber K, Reber S, Stoessel L, Waldmann E, Jank S, Eckardt K-U, Grundmann F, Vitinius F, de Zwaan M, Bertram A, Erim Y. Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation. Frontiers in psychiatry. 2018;9(23). [Link] 46. Lehner LJ, Reinke P, Horstrup JH, Rath T, Suwelack B, Kramer BK, Budde K, Banas B. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf) in kidney transplant patients in Germany: A multicenter, noninterventional study. Clin Transplant. 2018;32(1). [Link] 45. Leader A, Gafter-Gvili A, Benyamini N, Dreyer J, Calvarysky B, Amitai A, Yarchovsky-Dolberg O, Sharf G, Tousset E, Caspi O, Ellis M, Levi I, Raanani P, De Geest S. Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study. Clin Lymphoma Myeloma Leuk. 2018;18(9):e351-e62. [Link] 44. Jesus-Nunes AP, Morais-de-Jesus M, Dantas-Duarte A, Moreira TM, Argolo FC, Castro AO, Evangelista MA, Codes L, Bittencourt PL, Quarantini LC. The Portuguese Version of the Immunosuppressant Therapy Adherence Scale (ITAS) among Liver Transplant Recipient Patients: Translation and Psychometric Properties. Annals of hepatology. 2018;17(1):104-9. [Link] 43. Fellstrom B, Holmdahl J, Sundvall N, Cockburn E, Kilany S, Wennberg L. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden. Transplant Proc. 2018;50(10):3275-82. [Link] 42. Drick N, Seeliger B, Fuge J, Tudorache I, Greer M, Welte T, Haverich A, Gottlieb J. Self-reported non- adherence to immunosuppressive medication in adult lung transplant recipients-A single-center cross- sectional study. Clin Transplant. 2018;32(4):e13214. [Link] 41. Denhaerynck K, Berben L, Dobbels F, Russell CL, Crespo-Leiro MG, Poncelet AJ, De Geest S. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study. Am J Transplant. 2018;18(6):1447-60. [Link] 40. Abedini S, Goransson L, Cockburn E, Kilany S, Holdaas H. Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study. Transplantation direct. 2018;4(2):e338. [Link] 39. da Rocha D.F., Canabarro S.T., Figueiredo A.E., Sudbrack A.W. Evaluation of adherence to immunosuppressive therapy by self-report of patients submitted to renal transplantation (Avaliacao da adesao a terapia imunossupressora por autorrelato de pacientes submetidos ao transplante renal). Scientia Medica 2017 27:4. [Link] 38. Shemesh Y, Peles-Bortz A, Peled Y, HarZahav Y, Lavee J, Freimark D, Melnikov S. Feelings of indebtedness and guilt toward donor and immunosuppressive medication adherence among heart transplant (HTx) patients, as assessed in a cross-sectional study with the Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS). Clin Transplant. 2017;31(10). [Link] 37. Scheel J, Reber S, Stoessel L, Waldmann E, Jank S, Eckardt KU, Grundmann F, Vitinius F, de Zwaan M, Bertram A, Erim Y. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation. BMC Nephrol. 2017;18(1):107. [Link] 36. Hefner J, Csef EJ, Kunzmann V. Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors. Oncology nursing forum. 2017;44(6):E232-e40. [Link] 35. Gresch B, Kirsch M, Fierz K, Halter JP, Nair G, Denhaerynck K, De Geest S. Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study. Bone Marrow Transplant. 2017;52(2):304-6. [Link] 34. Silva AN, Moratelli L, Tavares PL, Marsicano EO, Pinhati RR, Colugnati FA, Lucchetti G, Sanders- Pinheiro H. Self-efficacy beliefs, locus of control, religiosity and non-adherence to immunosuppressive medications in kidney transplant patients. Nephrology (Carlton, Vic). 2016;21(11):938-43. [Link] 33. Reber S, Morawa E, Stossel L, Jank S, Vitinius F, Eckardt KU, Erim Y. Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample. Zeitschrift fur Psychosomatische Medizin und Psychotherapie. 2016;62(3):270-83. [Link] 32. Hermans M, Van Gaal L, Rezette I, Daci E, MacDonald K, Denhaerynck K, Vancayzeele S, De Meester L, Clemens A, Yee B, Abraham I. Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study). Primary care diabetes. 2016;10(6):425-33. [Link] 31. Brito DC, Marsicano EO, Grincenkov FR, Colugnati FA, Lucchetti G, Sanders-Pinheiro H. Stress, coping and adherence to immunosuppressive medications in kidney transplantation: a comparative study. Sao Paulo Med J. 2016;134(4):292-9. [Link] 30. Bessa AB, Felipe CR, Hannun P, Sayuri P, Felix MJ, Ruppel P, Ferreira AN, Cristelli MP, Viana L, Mansur JB, Basso G, Aguiar WF, Tedesco-Silva H, Medina-Pestana J. Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant. Ther Drug Monit. 2016;38(4):447-55. [Link] 29. Villa L, Sun D, Denhaerynck K, Vancayzeele S, Brie H, Hermans C, Aerts A, Levengood M, MacDonald K, Abraham I. Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium. The British journal of general practice: the journal of the Royal College of General Practitioners. 2015;65(630):e9-15. [Link] 28. Ruppar TM, Dobbels F, Lewek P, Matyjaszczyk M, Siebens K, De Geest SM. Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence. Int J Behav Med. 2015;22(6):699-708. [Link] 27. Pabst S, Bertram A, Zimmermann T, Schiffer M, de Zwaan M. Physician reported adherence to immunosuppressants in renal transplant patients: Prevalence, agreement, and correlates. Journal of psychosomatic research. 2015;79(5):364-71. [Link] 26. Massey EK, Tielen M, Laging M, Timman R, Beck DK, Khemai R, van Gelder T, Weimar W. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation. Transplantation. 2015;99(2):375-80. [Link] 25. Massey EK, Meys K, Kerner R, Weimar W, Roodnat J, Cransberg K. Young Adult Kidney Transplant Recipients: Nonadherent and Happy. Transplantation. 2015;99(8):e89-96. [Link] 24. Marsicano EO, Fernandes NS, Colugnati FA, Fernandes NM, De Geest S, Sanders-Pinheiro H. Multilevel Correlates of Non-Adherence in Kidney Transplant Patients Benefitting from Full Cost Coverage for Immunosuppressives: A Cross-Sectional Study. PLoS One. 2015;10(11):e0138869. [Link] 23. Glass TR, Sterne JA, Schneider MP, De Geest S, Nicca D, Furrer H, Gunthard HF, Bernasconi E, Calmy A, Rickenbach M, Battegay M, Bucher HC. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. Aids. 2015;29(16):2195-200. [Link] 22. Tielen M, van Exel J, Laging M, Beck DK, Khemai R, van Gelder T, Betjes MG, Weimar W, Massey EK. Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study. Journal of transplantation. 2014;2014:675301. [Link] 21. Tang HY, Sayers SL, Weissinger G, Riegel B. The role of depression in medication adherence among heart failure patients. Clinical nursing research. 2014;23(3):231-44. [Link] 20. Kirsch M, Gotz A, Halter JP, Schanz U, Stussi G, Dobbels F, De Geest S. Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplant. 2014;49(9):1223-30. [Link] 19. De Geest S, Burkhalter H, Bogert L, Berben L, Glass TR, Denhaerynck K. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transpl Int. 2014;27(7):657-66. [Link] 18. Burkhalter H, Wirz-Justice A, Cajochen C, Weaver TE, Steiger J, Fehr T, Venzin RM, De Geest S. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non- adherence: a cross-sectional, multi-center study. Clin Transplant. 2014;28(1):58-66. [Link] 17. Valente G, Rinaldi L, Sgambato M, Piai G. Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting.” Transplant Proc. 2013;45(3): 1273-1275. [Link] 16. Wang C, Wang G, Yi H, Tan J, Xu C, Fang X, Yang Y, Li H, Chen Q, Chen G. Symptom experienced three years after liver transplantation under immunosuppression in adults. PLoS One. 2013;8(11):e80584. [Link] 15. Swimberghe S, Ghislain PD, Daci E, Allewaert K, Denhaerynck K, Hermans C, Pacheco C, Vancayzeele S, Macdonald K, Abraham I. Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short- Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study). Annals of dermatology. 2013;25(1):28-35. [Link] 14. Massey EK, Tielen M, Laging M, Beck DK, Khemai R, van Gelder T, Weimar W. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. Journal of psychosomatic research. 2013;75(3):229-34. [Link] 13. Marsicano Ede O, Fernandes Nda S, Colugnati F, Grincenkov FR, Fernandes NM, De Geest S, Sanders-Pinheiro H. Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol. 2013;14:108. [Link] 12. Gebbia V, Bellavia M, Banna GL, Russo P, Ferrau F, Tralongo P, Borsellino N. Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer. Clinical lung cancer. 2013;14(4):390-8. [Link] 11. Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug design, development and therapy. 2013;7:1253-8. [Link] 10. Abraham I, Van Camp Y, Villa L, Denhaerynck K, Sun D, Vancayzeele S, Brie H, Aerts A, Hermans C, MacDonald K. Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients. Journal of clinical hypertension (Greenwich, Conn). 2013;15(9):663-73. [Link] 9. Lennerling A, Forsberg A. Self-reported non-adherence and beliefs about medication in a Swedish kidney transplant population. The open nursing journal. 2012;6:41-6. [Link] 8. Riegel B, Moelter ST, Ratcliffe SJ, Pressler SJ, De Geest S, Potashnik S, Fleck D, Sha D, Sayers SL, Weintraub WS, Weaver TE, Goldberg LR. Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail. 2011;17(4):340-8. [Link] 7. Pape L, Heidotting N, Ahlenstiel T. Once-daily tacrolimus extended-release formulation: 1 year after conversion in stable pediatric kidney transplant recipients. International journal of nephrology. 2011;2011:126251. [Link] 6. De Bleser L, Dobbels F, Berben L, Vanhaecke J, Verleden G, Nevens F, De Geest S. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int. 2011;24(9):882-91. [Link] 5. Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24(7):666-75. [Link] 4. Doesch AO, Mueller S, Konstandin M, Celik S, Erbel C, Kristen A, Frankenstein L, Koch A, Dengler TJ, Ehlermann P, Zugck C, De Geest S, Katus HA. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Transplant Proc. 2010;42(10):4238-42. [Link] 3. Dobbels F, Berben L, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation. 2010;90(2):205-19. [Link] 2. Van der Niepen P, Woestenburg A, Brie H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). The Annals of pharmacotherapy. 2009;43(5):849-61. [Link] 1. Noens L, van Lierde MA, De Bock R, Verhoef G, Zachee P, Berneman Z, Martiat P, Mineur P, Van Eygen K, MacDonald K, De Geest S, Albrecht T, Abraham I. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113(22):5401-11. [Link] 1Search in PubMed, Embase and Cochrane for Search terms/search strings: ‘BAASIS OR (Basel[tiab] AND Assessment[tiab] AND Adherence[tiab])’ (since start of Baasis until 20.02.2019) Arvanitis M., Moore A., Hur S., Curtis L.M., Ladner D., Wolf M.S. Online assessments of medication adherence and risks for inadequate adherence to critical medications in ambulatory populations. Journal of General Internal Medicine. Conference: 2019 Annual Meeting of the Society of General Internal Medicine, SGIM 2019. United States. 34 (2 Supplement) (pp S754), 2019. Date of Publication: May 2019. Aujoulat I., Janssen M., Libion F., Struyf C., Charles A.-S., Sokal E., Reding R. Self-management education needs in adolescent liver transplant recipients: A qualitative retrospective study. American Journal of Transplantation (2011) 11 SUPPL. 2 (498). Aujoulat I., Janssen M., Reding. R. The subjective impact of switching from prograf to advagraf in adolescents and young adults. Pediatric Transplantation (2011) 15 SUPPL. 1 (108). Aujoulat, I., M. Janssen, C. Struyf, A. S. Charles, E. Sokal, and R. Reding. Self-Management Education Needs in Adolescent Liver Transplant Recipients: A Qualitative Retrospective Study. Pediatric Transplantation 15 (2011): 134. Buhler L., Dutkowski P., Fausch K., Gluderer S., Graf N., Hirt-Minkowski P., Mullhaupt B., Schonholzer C., Schulz M., Venzin R., Wuthrich R.P. Adherence and tolerability of prolonged-release tacrolimus in stable kidney and liver transplant patients after conversion from immediate-release tacrolimus in routine clinical practice: The IMPROVE study. Swiss Medical Weekly. Conference: 49th Annual Meeting Swiss Society of Nephrology. Switzerland. 147 (Supplement 227) (pp 8S), 2017. Date of Publication: December 2017. Burkhalter H., Wirz-Justice A., Steiger J., Fehr T., Venzin R., Cajochen C., Weaver T., De Geest S. Poor sleep quality and daytime sleepiness are associated with worse biochemical parameters, psychological & behavioural functioning in renal transplant recipients. American Journal of Transplantation (2012) 12 SUPPL. 3 (250). Burkhalter, H., A. Wirz-justice, C. Cajochen, T. Weaver, J. Steiger, T. Fehr, R. Venzin, and S. De Geest. Timing Non-Adherence Is Associated with Chronotype in Renal Transplant Recipients. Sleep and Biological Rhythms 9, no. 4 (2011): 318. Cardoso B.D., Montagner J., Pegas K., Kist R., Neumann J., Pinheiro H.S., Garcia V.D., Keitel E. Association of histological finding in renal graft biopsy with non-adherence to immunlppressive treatment. American Journal of Transplantation. Conference: 2019 American Transplant Congress, ATC 2019. United States. 19 (Supplement 3) (pp 905), 2019. Date of Publication: April 2019. Day J., Hames A., Heneghan M., Hutton J., Samyn M., Dobbels F. Body image perception in young people with chronic liver disease. Pediatric Transplantation (2015) 19 SUPPL. 1 (75). De Almeida, S. S., L. Berben, E. Baumgartner, K. Denhaerynck, F. Dobbels, C. L. Russell, and S. De Geest. Variability in Health Care Worker’s Practice Patterns and Heart Transplant Patient’s Medication Adherence across 11 Countries – the Bright Study. Transplant International 28 (2015): 265. De Bleser L., Dobbels F., Berben L., Vanhaecke J., Verleden G., Nevens F., De Geest S. Higher self- reported non-adherence with co-medication compared to immunosuppressive drugs in heart, liver and lung transplant patients. Transplant International (2011) 24 SUPPL. 2 (200). De Simone P., Ducci J., Denhaerynck K., Schmid-Mohler G., Drent G., Dobbels F., Baldoni L., Filipponi F., De Geest S. Non adherence to immunosuppression after liver transplantation within the scope of the integrative model of behavior prediction1. Liver Transplantation (2010) 16 SUPPL. 1 (S132). De Simone, P., J. Ducci, G. Schmid-Moehler, L. Baldoni, P. Carrai, M. Elisei, S. Petruccelli, et al. Measuring Adherence in Adult Liver Transplant Patients. Liver Transplantation 15 (2009): S134 . De Simone, P., J. Ducci, K. Denhaerynck, G. Schmid-Mohler, G. Drent, F. Dobbels, L. Baldoni, S. De Geest, and F. Filipponi. Non Adherence to Immunosuppression after Liver Transplantation within the Scope of the Integrative Model of Behavior Prediction. American Journal of Transplantation 10 (2010): 531. Decorte A., Dobbels F., Knops N., Van Damme-Lombaerts R. How to improve motivation and medication adherence in adolescents? A case study. Pediatric Transplantation (2011) 15 SUPPL. 1 (105). Deininger, K. M., J. D. Hirsch, S. A. Graveline, A. A. Feist, S. M. Smith, J. A. Reich, J. LaFleur, et al. Relationship between Patient-Perceived Treatment Burden and Medication Adherence in Heart Transplant Recipients. Journal of Heart and Lung Transplantation 36, no. 4 (2017): S152. Dösch A., Müller S., Konstandin M., Celik S., Ehlermann P., Koch A., Katus H.A., Dengler T.J. Compliance under modified release tacrolimus in chronic stable patients after heart transplantation. Transplantation (2010) 90 SUPPL. 1 (743). Ducci J, De Simone P, Denhaerynck K, Dobbels F, De Geest S. Clinical consequences of subclinical non adherence to immunosuppression after liver transplantation. Transplant International 2013; 26 (Suppl. 2), pp.146; O280 . Gustavsen M., Lønning K., Midtvedt K., Reisæter A.V., Åsberg A. Adherence to immunosuppressive medications inrenal transplant recipients-different tools capture different patients. Transplantation 2018 102:7 Supplement 1 (S282). Gustavsen, M. T., K. Lønning, K. Midtvedt, A. V. Reisæter, and A. Åsberg. Validation of Tools for Annual Adherence Evaluation of Kidney Transplant Recipients. Transplant International 30 (2017): 152. Han, A., C. Choi, S. Y. Kim, S. Cho, M. J. Cho, C. Lee, S. Ahn, et al. Psychosocial Factors Associated with Medication Adherence Based on Self Reports in Kidney Allograft Recipients: Baseline Findings from the Prima (Improving Adherence to Immunosuppressive Therapy by Mobile Internet Application) Study. American Journal of Transplantation 16 (2016): 788. Hils S., Schmid A., Bogatyreva L., Hauschke D., Pisarski P. Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience. Transplantation (2014) 98 SUPPL. 1 (843). Hils, S., A. Schmid, L. Bogatyreva, D. Hauschke, A. Kramer-Zucker, and P. Pisarski. Telemedical Supported Aftercare after Living Kidney Transplantation-a Single Center Experience. Transplant International 28 (2015): 69. Kaiser T.E., Ejaz N.S., Tremblay S., Parrish N.J., Benavides J., Rehe B., Govil A., Woodle E.S., Alloway R.R. Technology triggered adherence intervention-preliminary findings. American Journal of Transplantation. Conference: 2019 American Transplant Congress, ATC 2019. United States. 19 (Supplement 3) (pp 394), 2019. Date of Publication: April 2019. Leader A., Benyamini N., De Geest S., Dreyer J., Calvarysky B., Gechler S., Amitai A., Jarchowsky-Dolberg O., Sharf G., Tousset E., Caspi O., Ellis M., Levi I., Gafter-Gvili A., Raanani P. The effect of adherence- encouraging interventions on adherence to tyrosine kinase inhibitor treatment in chronic myeloid leukemia (TAKE-IT): A pre-post intervention pilot study. Blood (2015) 126:23 (4034). Longuet, H., L. Preteseille, B. Sautenet, C. Barbet, E. Merieau, J. M. Halimi, P. Gatault, and M. Buchler. Impact of a Therapeutic Patient Education Program for Adult Kidney Transplant Recipients on Modification of Health Behaviors and Quality of Life. Transplant International 31 (2018): 9. Madden, A., S. Ivulich, M. Paraskeva, G. Snell, and M. Dooley. Do Your Patients Take Their Tablets? High Prevalence of Non-Adherence to Immunosuppression in Lung Transplant Recipients (Ltr). Journal of Heart and Lung Transplantation 35, no. 4 (2016): S124. Massey E., Tielen M., Laging M., Beck D., Khemai R., Van Gelder T., Weimar. Erasmus W. Psychological factors that predict non-adherence after kidney transplantation: A prospective cohort study. Transplantation (2014) 98 SUPPL. 1 (199). Date of Publication: 15 Jul 2014 Massey E.K., Tielen M., Laging M., Van Gelder T., Weimar W. Illness perceptions, treatment beliefs, attitudes, and adherence to medication: Changes over time after kidney transplantation Transplantation (2012) 94 SUPPL. 10S (868). Massey, E. K., M. Tielen, M. Laging, T. Van Gelder, and W. Weimar. Self-Regulatory Factors and Medication Adherence after Kidney Transplantation: Findings at 6 Weeks Post-Transplant. Transplant International 24 (2011): 245. Meys, K. M. E., J. Roodnat, W. Weimar, R. Kerner, M. G. H. Betjes, K. Cransberg, and E. K. Massey. Psychological Factors Associated with Medication Adherence among Young Adult Kidney Transplant Recipients. Pediatric Transplantation 17 (2013): 74. Ortiz, F., R. Roine, R. Malmström, and P. Koskinen. Health-Related Quality of Life and Adherence to Medication in Kidney Transplantation: A Longitudinal Analysis. American Journal of Transplantation 13 (2013): 438. Parrish, N., T. Kaiser, A. McCann, J. Aladimi, J. Harris, A. Govil, B. Abu Jawdeh, et al. Evaluation of Patient-Reported Nonadherence with Tacrolimus Level Variability in Renal Transplant Recipients. American Journal of Transplantation 16 (2016): 789. Pisarski, P., S. Hils, A. Schmid, A. Kramer-Zucker, and B. Jänigen. Telemedicin as an Innovative Project- Study in Adherence Improvement after Living Kideney Transplantation at the Transplantationcenter Freiburg. Transplant International 26 (2013): 73. Sanders-Pinheiro H., Marsicano E.O., Fernandes N.S., Brito D.C.S., Grincenkov F.R.S., Colugnati F., Fernandes N.S., De Geest S. Validation of the Brazilian-portuguese version of the basel assessment of adherence for immunosuppressives scale (BAASIS) in kidney transplant patients. American Journal of Transplantation (2012) 12 SUPPL. 3 (451). Sanders-Pinheiro, H., E. Marsicano, N. Fernandes, F. Colugnati, F. Grincencov, N. Fernandes, and S. De Geest. Risk Factors to Non-Adherence in Kidney Transplantation Patients Applying Triangulation Methodology in a Universal Access Medication Health System. American Journal of Transplantation 13 (2013): 273-74. Sanders-Pinheiro, H., S. Andresa, M. Lucas, M. Elisa, C. Moises, and B. Marcus. Modifiable Factors for Non-Adherence to Immunosuppressive Treatment in Kidney Transplant Recipients. Transplantation 98 (2014): 824-25. Scalso De Almeida S., Berben L., Baumgartner E., Denhaerynck K., Dobbels F., Russell C., De Geest S.M. Variability in health care workers’ practice patterns and heart transplant patients’ medication adherence across 11 countries-the bright study. Journal of Heart and Lung Transplantation (2015) 34:4 SUPPL. 1 (S235). Skogeland, U., A. Jonsson, L. Hallberg, and L. Hjelte. Improving Adherence to Anti-Rejection Medication after Lung Transplantation in People with Cystic Fibrosis. Pediatric Pulmonology 49 (2014): 451. Skogeland, U., L. Hjelte, and I. De Monestrol. Adherence to Medical Regimens after Lung Transplantation Can Be Increased. Pediatric Pulmonology 51 (2016): 478. Tielen, M., M. Laging, D. K. Beck, T. Van Gelder, M. G. H. Betjes, W. Weimar, and E. K. Massey. Importance of Early Medication Adherence for Long-Term Graft Survival: A Prospective, Single-Centre Cohort Study. Transplantation 100, no. 7 (2016): S431. Tielen, M., M. Laging, T. Van Gelder, W. Weimar, and E. K. Massey. Q-Methodology to Explore Attitudes Towards Adherence in Recently Transplanted Kidney Patients. Transplantation 94 (2012): 184. Vengadessane S., Le Roy C., Sauvageon H., Madelaine I., Pillebout E., Viglietti D., Deville L. Assessment of adherence to immunosuppressive therapy in kidney transplanted patients. European Journal of Hospital Pharmacy 2018 25 Supplement 1 (A120-). Wessels-Bakker M. Prevalence of psychological distress and the association with medication nonadherence among lung transplant patients. Journal of Psychosomatic Research. Conference: Seventh Annual Scientific Conference of the European Association of Psychosomatic Medicine (EAPM). Netherlands. 121 (pp 141-142), 2019. Date of Publication: June 2019.Published articles that used the BAASIS© (status 12.09.2023)1
https://www.ncbi.nlm.nih.gov/pubmed/?term=BAASIS+OR+(Basel%5Btiab%5D+AND+Assessment%5Btiab%5D +AND+Adherence%5Btiab%5D)Published abstracts that used the BAASIS© (status 29.04.2020)